Persistent Asset Partners Ltd

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 2056052 HONG KONG, K3

Back to CRBP Full portfolio

Position in CRBP

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$721,500

-$322,912 QoQ

Shares Held

76,919

-30.8% QoQ

Ownership

0.398%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#27

of 106 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRBP Over Time

Shares Held

Position Value (USD)

Derivatives in CRBP

reported options exposure · as of Jun 30, 2026

CallValue

$15,147

CallShares

1,615

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. CRBP ranks #21 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	38,726	$7,252,604
2	ABVX	Abivax S.A.	44,256	$5,897,553
3	COGT	Cogent Biosciences, Inc.	138,272	$5,351,125
4	BMRN	Biomarin Pharmaceutical Inc	79,933	$4,573,766
5	VKTX	Viking Therapeutics, Inc.	112,736	$4,397,831
6	EWTX	Edgewise Therapeutics, Inc.	69,441	$2,821,387
7	KOD	Kodiak Sciences Inc.	56,052	$2,183,785
8	IMCR	Immunocore Holdings plc	65,214	$2,070,544

All Filings in CRBP

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,147	1,615	+453.1%	Call	Sole	2026-08-07
2026-06-30	$721,500	76,919	-30.8%	Shares	Sole	2026-08-07
2026-03-31	$2,741	292	—	Call	Sole	2026-05-12
2026-03-31	$1,044,412	111,226	+1588.6%	Shares	Sole	2026-05-12
2025-12-31	$53,618	6,587	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.